Lyra Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
15 May 2026	Form 4: Smith W Bradford, Director Returned 640 shares to the issuer
03 Apr 2026	Form 4: Palasis Maria, Director Returned 2,000 shares to the issuer
03 Apr 2026	Form 4: Cavalier Jason, Principal Financial Officer Returned 667 shares to the issuer
08 Jan 2026	Form 4: Cavalier Jason, Chief Financial Officer Sold 769 shares ($2.59K)
08 Jan 2026	Form 4: Palasis Maria, Director Sold 1,702 shares ($5.73K)
13 Nov 2025	Form 4: Perceptive Advisors Llc, 10% owner and 3 others Sold 5,320 shares ($23K) · Sold 8,745 shares ($35.5K) · Sold 31,810 shares ($124K)
10 Nov 2025	Form 4: Perceptive Advisors Llc, 10% owner and 3 others Sold 32,149 shares ($167K) · Sold 19,739 shares ($93.7K) · Sold 18,502 shares ($84K)
03 Oct 2025	Form 4: Palasis Maria, Director Granted 3,667 Employee Stock Option (right to buy)
14 Jul 2025	Form 4: Palasis Maria, Director Sold 1,565 shares ($13.9K)
14 Jul 2025	Form 4: Cavalier Jason, Chief Financial Officer Sold 684 shares ($6.09K)
16 May 2025	Form 4: Merrifield C Ann, Director Granted 32,000 Restricted Stock Units
16 May 2025	Form 4: Tobin James R, Director Granted 32,000 Restricted Stock Units
16 May 2025	Form 4: snyderman nancy lynn Md, Director Granted 32,000 Restricted Stock Units
16 May 2025	Form 4: Smith W Bradford, Director Granted 32,000 Restricted Stock Units
10 Jan 2025	Form 4: Palasis Maria, Director Received 800,000 shares as a grant or award
10 Jan 2025	Form 4: Cavalier Jason, Chief Financial Officer Received 420,000 shares as a grant or award
11 Dec 2024	Form 4: Palasis Maria, Director Granted 183,333 Employee Stock Option (right to buy)
11 Dec 2024	Form 4: Waksal Harlan, Director Disposed of 128,333 Performance-based Restricted Stock Units (Grant/Award Acquisition)
18 Oct 2024	Form 4: Palasis Maria, Director Received 300,000 shares as a grant or award
18 Oct 2024	Form 4: Cavalier Jason, Chief Financial Officer Received 100,000 shares as a grant or award

Comments